{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/comboltr",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalTool/0.6-DRAFT",
      "sc:additionalType": "Script",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0154"
        },
        {
          "@id": "edam:topic_2640"
        },
        {
          "@id": "edam:topic_3474"
        }
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1101/2021.04.16.439989"
      },
      "sc:description": "comboLTR is a new polynomial regression-based framework for modeling anti-cancer effects of drug combinations in various doses and across different cancer cell lines.",
      "sc:featureList": [
        {
          "@id": "edam:operation_0303"
        },
        {
          "@id": "edam:operation_4009"
        },
        {
          "@id": "edam:operation_3659"
        }
      ],
      "sc:license": "MIT",
      "sc:name": "comboLTR",
      "sc:softwareHelp": {
        "@id": "https://github.com/aalto-ics-kepaco/ComboLTR/blob/main/readme.pdf"
      },
      "sc:url": "https://github.com/aalto-ics-kepaco/ComboLTR"
    },
    {
      "@id": "https://doi.org/10.1101/2021.04.16.439989",
      "@type": "sc:CreativeWork"
    }
  ]
}